2025-08-14 - Analysis Report
Okay, here's an analysis of Equinix Inc. (EQIX) based on the provided data, presented in English with key numbers and a concise overview:

## Equinix Inc. (EQIX) Analysis

**Company Overview:** Equinix Inc. is a global interconnection and data center company.

**1. Performance vs. S&P 500 (VOO)**

*   **EQIX Cumulative Return:** 46.19%
*   **VOO Cumulative Return:** 86.23%
*   **Return Disparity (EQIX - VOO):** -40.04%
*   **Disparity Range:** Max: 68.5, Min: -17.2, Current: -17.2
*   **Relative Disparity:** 0.0

**Analysis:** EQIX has significantly underperformed the S&P 500 over the tracked period. The current return disparity is at the minimum end of its historical range.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | -6.0%  | 0.0%   | -9.0%  | 0.1  | 44.4  |
| 2016-2018  | -25.0% | 63.4%  | -20.0% | -0.0 | 34.5  |
| 2017-2019  | 24.0%  | 63.4%  | 1.0%   | -0.0 | 57.1  |
| 2018-2020  | 44.0%  | 63.7%  | 17.0%  | -0.0 | 69.9  |
| 2019-2021  | 75.0%  | 63.7%  | 26.0%  | 0.0  | 82.8  |
| 2020-2022  | 11.0%  | 68.5%  | 4.0%   | 0.1  | 64.1  |
| 2021-2023  | 1.0%   | 68.5%  | -19.0% | 1.0  | 78.8  |
| 2022-2024  | 26.0%  | 70.8%  | 0.0%   | 1.1  | 92.3  |
| 2023-2025  | 1.0%   | 72.4%  | -51.0% | 0.9  | 76.7  |

**Analysis:**
*   The alpha values fluctuate significantly, indicating inconsistent outperformance relative to its benchmark.
*   Beta values are generally low (close to 0 or slightly negative in some periods), suggesting EQIX has not been highly correlated with the overall market.  More recently, the beta has increased, suggesting a higher correlation.
*   The negative alpha for the recent period (2023-2025) is concerning, as is the high MDD.

**2. Recent Price Action**

*   **Current Price:** 784.0
*   **Previous Close:** 787.32, **Change:** -0.42
*   **5-Day Moving Average:** 780.72
*   **20-Day Moving Average:** 786.15
*   **60-Day Moving Average:** 826.67

**Analysis:** The stock is currently trading below its 20-day and 60-day moving averages, suggesting potential short-term weakness. The small change relative to the previous close does not indicate a major price event.

**3. Market Risk Indicator (MRI) and Other Indicators**

*   **MRI:** 0.3234 (Low Risk)
*   **RSI:** 47.56 (Neutral)
*   **PPO:** 0.25 (Neutral)
*   **Hybrid Signal:** Buy 80% of cash (1 shares - Caution - MRI:0.35) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-08-01)
*   **Delta_Previous_Relative_Divergence (20-day):** -0.2 (Short-term Decrease)
*   **Expected Return:** 1961.4% (Long-term)

**Analysis:** The MRI indicates a low-risk environment for the overall market. The RSI is neutral, suggesting neither overbought nor oversold conditions. The negative change in relative divergence signals short-term underperformance compared to the benchmark. The very high expected return should be viewed with caution.

**4. Recent News & Significant Events**

*   **Recent Headlines:** Discuss major business developments, regulatory changes, market events, analyst discussions, stock volatility, and expert advice to monitor news.

**Analysis:** Recent news points to increased volatility and the need to stay informed about company-specific developments and broader market trends.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue        |
| :----------- | :---- | :------------- |
| 2025-07-30 | 3.76  | 2.26 B$        |
| 2025-04-30 | 3.52  | 2.23 B$        |
| 2024-10-30 | 3.11  | 2.20 B$        |
| 2024-08-07 | 3.17  | 2.16 B$        |
| 2025-07-30 | 3.17  | 2.16 B$        |

**Analysis:** EPS and revenue have generally been increasing over the last few quarters, suggesting positive growth. The last duplicate entry needs verification to be accurate.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-06-30 | \$2.26B  | 51.95%       |
| 2025-03-31 | \$2.23B  | 51.28%       |
| 2024-12-31 | \$2.26B  | 47.10%       |
| 2024-09-30 | \$2.20B  | 50.11%       |
| 2024-06-30 | \$2.16B  | 49.88%       |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
| :--------- | :-------- | :------- |
| 2025-06-30 | \$14.08B | 2.61%    |
| 2025-03-31 | \$13.89B | 2.47%    |
| 2024-12-31 | \$13.53B | -0.10%   |
| 2024-09-30 | \$13.59B | 2.19%    |
| 2024-06-30 | \$12.28B | 2.45%    |

**Analysis:** Revenue has been growing consistently. Profit margins are healthy and stable. Equity has been increasing, and ROE is generally positive, although there was a negative ROE in Q4 2024.

**7. Overall Assessment**

Equinix (EQIX) is a company with solid fundamentals, as evidenced by its consistent revenue growth, healthy profit margins, and increasing equity. Recent earnings reports align with this positive trajectory. However, it has significantly underperformed the S&P 500, and the recent negative alpha is concerning. The stock is currently trading below its short-term moving averages, suggesting potential weakness. The recent news indicates volatility, requiring close monitoring. While the MRI signals low overall market risk, the disparity in returns relative to the S&P 500 warrants caution. The very high expected return should be critically evaluated.

**In Summary:** EQIX appears to be a fundamentally sound company, but its recent underperformance and volatility suggest that investors should proceed with caution and carefully consider the factors contributing to this underperformance.
